Filing Details
- Accession Number:
- 0001127602-21-006676
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-19 14:17:58
- Reporting Period:
- 2021-02-12
- Accepted Time:
- 2021-02-19 14:17:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 920148 | Laboratory Corp Of America Holdings | LH | Services-Medical Laboratories (8071) | 133757370 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1398138 | J Peter Wilkinson | 231 Maple Avenue Burlington NC 27215 | Svp, Chief Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-02-12 | 187 | $0.00 | 710 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-12 | 62 | $238.26 | 648 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2021-02-12 | 680 | $0.00 | 1,328 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-12 | 201 | $238.26 | 1,127 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2021-02-18 | 1,533 | $146.59 | 2,660 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-18 | 2,317 | $241.51 | 343 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-02-18 | 633 | $182.51 | 976 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit | Disposition | 2021-02-12 | 187 | $0.00 | 187 | $0.00 |
| Common Stock | Restricted Stock Unit | Disposition | 2021-02-12 | 680 | $0.00 | 680 | $0.00 |
| Common Stock | Non-qualified Stock Options | Disposition | 2021-02-18 | 1,533 | $0.00 | 1,533 | $146.59 |
| Common Stock | Non-qualified Stock Options | Disposition | 2021-02-18 | 633 | $0.00 | 633 | $182.51 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,347 | No | 4 | M | Direct | ||
| 1,667 | No | 4 | M | Direct | ||
| 767 | 2020-02-12 | 2029-02-11 | No | 4 | M | Direct |
| 1,267 | 2021-02-04 | 2030-02-03 | No | 4 | M | Direct |
Footnotes
- Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
- Stock withholding to satisfy tax withholding obligations.
- The price of $241.5146 per share represents a weighted average of sales prices ranging from $240.92 to $241.651 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a securityholder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 12, 2020.
- This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
- Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
- The option vests in three equal annual installments beginning on the date reflected in this column.
Billionaire Hedge Funds
